Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
Rheumatology (Oxford)
.
2008 Oct;47(10):1591; author reply 1591.
doi: 10.1093/rheumatology/ken322.
Epub 2008 Aug 1.
Authors
A K Bhalla
,
M Samaranayaka
PMID:
18676499
DOI:
10.1093/rheumatology/ken322
No abstract available
Publication types
Comment
Letter
MeSH terms
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy
Drug Eruptions / etiology*
Drug Monitoring / methods
Humans
Practice Guidelines as Topic*
Substances
Antirheumatic Agents